BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 9796255)

  • 41. Cystine stones: the efficacy of percutaneous and shock wave lithotripsy.
    Cranidis AI; Karayannis AA; Delakas DS; Livadas CE; Anezinis PE
    Urol Int; 1996; 56(3):180-3. PubMed ID: 8860740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine.
    Pak CY; Fuller C; Sakhaee K; Zerwekh JE; Adams BV
    J Urol; 1986 Nov; 136(5):1003-8. PubMed ID: 3534301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Results of long-term treatment of cystine lithiasis with D-penicillamine].
    Bec P; Lacombe JL; Malha F; Pujo JM
    Nephrologie; 1984; 5(5):228-31. PubMed ID: 6531062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Beneficial effect of angiotensin converting enzyme inhibitor treatment in severe cystine urolithiasis].
    Rogowska-Kalisz A; Bilińska W; Nowicki M; Olejniczak D; Chilarski A
    Pol Merkur Lekarski; 2003 Mar; 14(81):253-5. PubMed ID: 12914108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria.
    Dolin DJ; Asplin JR; Flagel L; Grasso M; Goldfarb DS
    J Endourol; 2005 Apr; 19(3):429-32. PubMed ID: 15865542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of sodium intake on cystinuria with and without tiopronin treatment.
    Lindell A; Denneberg T; Edholm E; Jeppsson JO
    Nephron; 1995; 71(4):407-15. PubMed ID: 8587620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cystinuria].
    Prot-Bertoye C; Daudon M; Tostivint I; Dousseaux MP; Defazio J; Traxer O; Knebelmann B; Courbebaisse M
    Nephrol Ther; 2021 Apr; 17S():S100-S107. PubMed ID: 33910689
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies of urinary cystine precipitation in vitro: ontogeny of cystine nephrolithiasis and identification of meso-2,3-dimercaptosuccinic acid as a potential therapy for cystinuria.
    Parvex P; Rozen R; Dziarmaga A; Goodyer P
    Mol Genet Metab; 2003 Dec; 80(4):419-25. PubMed ID: 14654355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of a metabolic stone clinic on management of patients with cystinuria: 5 years follow-up.
    Haritopoulos K; Fojtik P; Cross W; Cartledge J
    Clin Ter; 2010; 161(4):341-4. PubMed ID: 20931157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Imaging and surgical utilization for pediatric cystinuria patients: A single-institution cohort study.
    Varda BK; Johnson EK; Johnson KL; Rosoklija I; Baum MA; Nelson CP
    J Pediatr Urol; 2016 Apr; 12(2):106.e1-7. PubMed ID: 26597229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary excretion of free cystine and the tiopronin-cysteine-mixed disulfide during long term tiopronin treatment of cystinuria.
    Lindell A; Denneberg T; Jeppsson JO
    Nephron; 1995; 71(3):328-42. PubMed ID: 8569983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Do Urinary Cystine Parameters Predict Clinical Stone Activity?
    Friedlander JI; Antonelli JA; Canvasser NE; Morgan MSC; Mollengarden D; Best S; Pearle MS
    J Urol; 2018 Feb; 199(2):495-499. PubMed ID: 28916274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric urolithiasis--evaluation of risk factors in 95 children.
    Erbagci A; Erbagci AB; Yilmaz M; Yagci F; Tarakcioglu M; Yurtseven C; Koyluoglu O; Sarica K
    Scand J Urol Nephrol; 2003; 37(2):129-33. PubMed ID: 12745721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of surgical intervention on renal function in cystinuria.
    Döven SS; Delibaş A; Taşkınlar H; Naycı A
    J Bras Nefrol; 2018; 40(3):256-260. PubMed ID: 29958305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cystinuria poorly responding to treatment - the risk of chronic kidney disease.
    Śliwińska WL; Kade G; Niemczyk S
    Pol Merkur Lekarski; 2021 Feb; 49(289):60-63. PubMed ID: 33713096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stone clustering of patients with cystine urinary stone formation.
    Purohit RS; Stoller ML
    Urology; 2004 Apr; 63(4):630-4; discussion 634-5. PubMed ID: 15072865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cystinuria in the dog: clinical studies during 14 years of medical treatment.
    Hoppe A; Denneberg T
    J Vet Intern Med; 2001; 15(4):361-7. PubMed ID: 11467594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medical and surgical therapy of the cystine stone patient.
    Ng CS; Streem SB
    Curr Opin Urol; 2001 Jul; 11(4):353-8. PubMed ID: 11429493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment alternatives for urinary system stone disease in preschool aged children: results of 616 cases.
    Sen H; Seckiner I; Bayrak O; Erturhan S; Demirbağ A
    J Pediatr Urol; 2015 Feb; 11(1):34.e1-5. PubMed ID: 25697981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Journey of a cystinuric patient with a long-term follow-up from a medical stone clinic: necessity to be SaFER (stone and fragments entirely removed).
    Moore SL; Somani BK; Cook P
    Urolithiasis; 2019 Apr; 47(2):165-170. PubMed ID: 29696300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.